Top

Published in:

01-06-2012 | Editorial

Molecular aspects of prostate cancer

Authors: M. V. Cronauer, Z. Culig

Published in: World Journal of Urology | Issue 3/2012

Excerpt

Molecular biology has altered the face of biomedical research. Due to new techniques in molecular biology, our knowledge of pathological processes has grown exponentially over the last decades. Today, cancer research has become a multidisciplinary task, requiring basic scientists as well as clinicians. However, only when scientists and clinicians bridge the gap between laboratory and clinic, a rapid translation of the experimental findings to the clinic will take place. …

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef

Hodgson MC, Bowden WA, Agoulnik IU (2011) Androgen receptor footprint on the way to prostate cancer progression. World J Urol. doi:10.1007/s00345-011-0743-7

Nadiminty N, Gao AC (2011) Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives. World J Urol. doi:10.1007/s00345-011-0771-3

Culig Z, Santer FR (2011) Androgen receptor co-activators in the regulation of cellular events in prostate cancer. World J Urol. doi:10.1007/s00345-011-0797-6

Jain G, Cronauer MV, Schrader M, Möller P, Marienfeld RB (2011) NF-κB signaling in prostate cancer: a promising therapeutic target? World J Urol. doi:10.1007/s00345-011-0792-y

Sadar MD (2011) Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer. World J Urol. doi:10.1007/s00345-011-0745-5

Hu R, Dunn TA, Wei S, Isharwal S, Veltri RW, Humphreys E, Han M, Partin AW, Vessella RL, Isaacs WB, Bova GS, Luo J (2009) Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res 69:16–22PubMedCrossRef

Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR (2011) Androgen receptor variants occur frequently in castration resistant prostate cancer metastases. PLoS ONE 6(11):e27970PubMedCrossRef

Vinarskaja A, Goering W, Ingenwerth M, Schulz WA (2011) ID4 is frequently downregulated and partially hypermethylated in prostate cancer. World J Urol. doi:10.1007/s00345-011-0750-8

10.

Stope MB, Schubert T, Staar D, Rönnau C, Streitbörger A, Kroeger N, Kubisch C, Zimmermann U, Walther R, Burchardt M (2012) Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells. World J Urol. doi:10.1007/s00345-012-0843-z

11.

Streicher W, Zengerling F, Laschak M, Weidemann W, Höpfner M, Schrader AJ, Jentzmik F, Schrader M, Cronauer MV (2012) AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR-variants in prostate cancer cells. World J Urol. doi:10.1007/s00345-012-0842-0

Title: Molecular aspects of prostate cancer
Authors: M. V. Cronauer
Z. Culig
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: World Journal of Urology / Issue 3/2012
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-012-0853-x

At a glance: The STEP trials

Springer Medicine

Molecular aspects of prostate cancer

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2012

Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC)

Androgen receptor co-activators in the regulation of cellular events in prostate cancer

Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases

Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives

The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy

Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy